Peptide-Directed, Hypoxia-Sensitive AAV System Enables Tumor-Specific Delivery of Chemokines and PNAi in Non-Small Cell Lung Cancer
In a bold leap toward precision oncology, researchers have proposed an innovative adeno-associated virus (AAV) vector system engineered to selectively target non-small cell lung cancer (NSCLC) cells within their uniquely hostile microenvironment....
Read moreDetails

